P

PDS Biotechnology Corp

PDSB

3.23000
USD
-0.34
(-9.52%)
Market Closed
Volume
8,792
EPS
0
Div Yield
0
P/E
-3
Market Cap
120,216,680
News

Title: PDS Biotechnology Corp

Sector: Healthcare
Industry: Biotechnology
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.